{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:40:24Z","timestamp":1790048424534,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1776,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ajpath.2014.10.013","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T22:03:54Z","timestamp":1417557834000},"page":"325-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["A New Mdr2\u2212\/\u2212 Mouse Model of Sclerosing Cholangitis with Rapid Fibrosis Progression, Early-Onset Portal Hypertension, and Liver Cancer"],"prefix":"10.1016","volume":"185","author":[{"given":"Naoki","family":"Ikenaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan B.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna Y.","family":"Sverdlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingen","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2014.10.013_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2014.10.013_bib2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2014.10.013_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00054725-200501000-00009","article-title":"Primary sclerosing cholangitis","volume":"11","author":"Talwalkar","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ajpath.2014.10.013_bib5","doi-asserted-by":"crossref","first-page":"167sr161","DOI":"10.1126\/scitranslmed.3004700","article-title":"Therapy for fibrotic diseases: nearing the starting line","volume":"5","author":"Friedman","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2014.10.013_bib6","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/hep.23144","article-title":"Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis","volume":"50","author":"Patsenker","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinre.2011.03.009","article-title":"Therapy for hepatic fibrosis: revisiting the preclinical models","volume":"35","author":"Bissell","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib8","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1053\/gast.2002.37069","article-title":"Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15","volume":"123","author":"Hillebrandt","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ng1599","article-title":"Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans","volume":"37","author":"Hillebrandt","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2014.10.013_bib10","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1073\/pnas.94.20.10663","article-title":"Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses","volume":"94","author":"Shi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2014.10.013_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","article-title":"MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes","volume":"27","author":"Trauner","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ajpath.2014.10.013_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2014.10.013_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.20022","article-title":"Spontaneous cholecysto- and hepatolithiasis in Mdr2-\/- mice: a model for low phospholipid-associated cholelithiasis","volume":"39","author":"Lammert","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib15","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene: a novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib16","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib17","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)-\/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes","volume":"43","author":"Popov","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib18","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.2741\/3526","article-title":"Liver diseases related to MDR3 (ABCB4) gene deficiency","volume":"14","author":"Gonzales","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.ajpath.2014.10.013_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.gastro.2008.03.044","article-title":"ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults","volume":"135","author":"Ziol","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/gast.1996.v111.pm8698195","article-title":"Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene","volume":"111","author":"Van Nieuwkerk","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib21","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1053\/j.gastro.2011.01.040","article-title":"Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice","volume":"140","author":"Popov","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib22","doi-asserted-by":"crossref","first-page":"G323","DOI":"10.1152\/ajpgi.00394.2009","article-title":"Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis","volume":"298","author":"Popov","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2007.11.021","article-title":"Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies","volume":"48","author":"Popov","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00000478-199311000-00004","article-title":"Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease","volume":"17","author":"Ferrell","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0168-8278(97)80020-7","article-title":"The role of bile salt composition in liver pathology of mdr2 (-\/-) mice: differences between males and females","volume":"26","author":"van Nieuwerk","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib26","first-page":"1221","article-title":"Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease","volume":"139","author":"Milani","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib27","first-page":"1258","article-title":"The usefulness of the reticulin stain in the differential diagnosis of liver nodules on fine-needle aspiration biopsy cell block preparations","volume":"10","author":"Bergman","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hep.25969","article-title":"Mouse model of primary biliary cirrhosis with progressive fibrosis: are we there yet?","volume":"57","author":"Popov","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib29","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib30","first-page":"599A","article-title":"BALB-Abcb4 knockout mice as new model for spontaneous liver fibrogenesis: genetic strain differences determine severity of fibrosis","volume":"42","author":"Hillebrandt","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib31","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1002\/pmic.200600580","article-title":"Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis","volume":"6","author":"Henkel","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.ajpath.2014.10.013_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.23274","article-title":"Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-\/- mice","volume":"51","author":"Roderfeld","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.alcohol.2004.08.007","article-title":"Effects of periadolescent ethanol exposure on alcohol preference in two BALB substrains","volume":"34","author":"Blizard","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib34","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/thy.2006.16.651","article-title":"Differential susceptibility of BALB\/c and BALB\/cBy mice to Graves' hyperthyroidism","volume":"16","author":"Seetharamaiah","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.ajpath.2014.10.013_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1586\/egh.12.83","article-title":"Assessing portal hypertension in liver diseases","volume":"7","author":"Berzigotti","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib36","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","article-title":"Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis","volume":"50","author":"Ripoll","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib37","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis","volume":"37","author":"Abraldes","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib38","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2004.01.017","article-title":"Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis","volume":"40","author":"Villanueva","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib39","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1572-0241.2006.00453.x","article-title":"Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis","volume":"101","author":"Turnes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajpath.2014.10.013_bib40","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1053\/j.gastro.2012.07.097","article-title":"Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection","volume":"143","author":"Patin","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.10.013_bib41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014006075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014006075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T11:57:20Z","timestamp":1576238240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944014006075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0002944014006075"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.10.013","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A New Mdr2\u2212\/\u2212 Mouse Model of Sclerosing Cholangitis with Rapid Fibrosis Progression, Early-Onset Portal Hypertension, and Liver Cancer","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}